It is rewarding to advise healthcare and life sciences companies that make a real impact on the lives of patients and society as a whole.
Dexter provides mergers and acquisitions (M&A) advisory services to owner-managed businesses, private equity-backed businesses and private equity clients in the healthcare sector.
Dexter has experience working on sell-side and buy-side transactions with specific expertise in the adult specialist care and children’s services sectors.
Prior to joining Lincoln, Dexter worked at Deloitte as an Assistant Director in its healthcare and life sciences M&A team. Previously, he worked at RSM in its M&A and private equity team where he advised on transactions across a range of sectors.
Dexter earned a Bachelor of Science with honors in business administration from the University of Bath. He holds a certificate in finance, accounting and business from the Institute of Chartered Accountants in England and Wales and a corporate finance qualification from the Chartered Institute for Securities and Investment.
Recent Transactions in Healthcare
Lincoln International advised Proclinic Group, a portfolio company of Miura Partners, on the acquisition of Meditrans
Lincoln International advised Frazier Lifesciences Acquisition Corporation on merger with NewAmsterdam Pharma Holding
Lincoln International advised Pfingsten Partners on the sale of Full Spectrum Group to CBRE Group
Lincoln International advised Rarebreed, a portfolio company of Trilantic Capital Partners and Halle Capital Management, on receiving significant investment from Revelstoke Capital Partners
Lincoln International advised Corus a portfolio company of Careventures and Quadrum Capital on the refinancing and acquisition of Nordentic
Meet our Senior Team
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Managing Director | Management Board MemberFrankfurt